198 related articles for article (PubMed ID: 36864519)
1. An integrated genetic analysis of epileptogenic brain malformed lesions.
Fujita A; Kato M; Sugano H; Iimura Y; Suzuki H; Tohyama J; Fukuda M; Ito Y; Baba S; Okanishi T; Enoki H; Fujimoto A; Yamamoto A; Kawamura K; Kato S; Honda R; Ono T; Shiraishi H; Egawa K; Shirai K; Yamamoto S; Hayakawa I; Kawawaki H; Saida K; Tsuchida N; Uchiyama Y; Hamanaka K; Miyatake S; Mizuguchi T; Nakashima M; Saitsu H; Miyake N; Kakita A; Matsumoto N
Acta Neuropathol Commun; 2023 Mar; 11(1):33. PubMed ID: 36864519
[TBL] [Abstract][Full Text] [Related]
2. Somatic variants in diverse genes leads to a spectrum of focal cortical malformations.
Lai D; Gade M; Yang E; Koh HY; Lu J; Walley NM; Buckley AF; Sands TT; Akman CI; Mikati MA; McKhann GM; Goldman JE; Canoll P; Alexander AL; Park KL; Von Allmen GK; Rodziyevska O; Bhattacharjee MB; Lidov HGW; Vogel H; Grant GA; Porter BE; Poduri AH; Crino PB; Heinzen EL
Brain; 2022 Aug; 145(8):2704-2720. PubMed ID: 35441233
[TBL] [Abstract][Full Text] [Related]
3. The genomic landscape across 474 surgically accessible epileptogenic human brain lesions.
López-Rivera JA; Leu C; Macnee M; Khoury J; Hoffmann L; Coras R; Kobow K; Bhattarai N; Pérez-Palma E; Hamer H; Brandner S; Rössler K; Bien CG; Kalbhenn T; Pieper T; Hartlieb T; Butler E; Genovese G; Becker K; Altmüller J; Niestroj LM; Ferguson L; Busch RM; Nürnberg P; Najm I; Blümcke I; Lal D
Brain; 2023 Apr; 146(4):1342-1356. PubMed ID: 36226386
[TBL] [Abstract][Full Text] [Related]
4. Somatic variants in new candidate genes identified in focal cortical dysplasia type II.
Zhang Z; Gao K; Liu Q; Zhou J; Li X; Lang N; Liu M; Wang T; Zhang J; Wang H; Dong Y; Ji T; Wang S; Liu X; Jiang Y; Cai L; Wu Y
Epilepsia; 2020 Apr; 61(4):667-678. PubMed ID: 32216069
[TBL] [Abstract][Full Text] [Related]
5. Identification of genetic characteristics in pediatric epilepsy with focal cortical dysplasia type 2 using deep whole-exome sequencing.
Xu Y; Zhao R; Wang M; Wang XH; Wang Y; Li H; Ma YY; Wu BB; Zhou YF
Mol Genet Genomic Med; 2022 Dec; 10(12):e2086. PubMed ID: 36342087
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia.
Jha R; Kurup A; Kovilapu UB; Ranjan R; Sondhi V
Brain Dev; 2022 Feb; 44(2):166-172. PubMed ID: 34756499
[TBL] [Abstract][Full Text] [Related]
7. Detection of brain somatic variation in epilepsy-associated developmental lesions.
Bedrosian TA; Miller KE; Grischow OE; Schieffer KM; LaHaye S; Yoon H; Miller AR; Navarro J; Westfall J; Leraas K; Choi S; Williamson R; Fitch J; Kelly BJ; White P; Lee K; McGrath S; Cottrell CE; Magrini V; Leonard J; Pindrik J; Shaikhouni A; Boué DR; Thomas DL; Pierson CR; Wilson RK; Ostendorf AP; Mardis ER; Koboldt DC
Epilepsia; 2022 Aug; 63(8):1981-1997. PubMed ID: 35687047
[TBL] [Abstract][Full Text] [Related]
8. Deep histopathology genotype-phenotype analysis of focal cortical dysplasia type II differentiates between the GATOR1-altered autophagocytic subtype IIa and MTOR-altered migration deficient subtype IIb.
Honke J; Hoffmann L; Coras R; Kobow K; Leu C; Pieper T; Hartlieb T; Bien CG; Woermann F; Cloppenborg T; Kalbhenn T; Gaballa A; Hamer H; Brandner S; Rössler K; Dörfler A; Rampp S; Lemke JR; Baldassari S; Baulac S; Lal D; Nürnberg P; Blümcke I
Acta Neuropathol Commun; 2023 Nov; 11(1):179. PubMed ID: 37946310
[TBL] [Abstract][Full Text] [Related]
9. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
[TBL] [Abstract][Full Text] [Related]
10. Assessment of genetic variant burden in epilepsy-associated brain lesions.
Niestroj LM; May P; Artomov M; Kobow K; Coras R; Pérez-Palma E; Altmüller J; Thiele H; Nürnberg P; Leu C; Palotie A; Daly MJ; Klein KM; Beschorner R; Weber YG; Blümcke I; Lal D
Eur J Hum Genet; 2019 Nov; 27(11):1738-1744. PubMed ID: 31358956
[TBL] [Abstract][Full Text] [Related]
11. A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II.
Zhao S; Li Z; Zhang M; Zhang L; Zheng H; Ning J; Wang Y; Wang F; Zhang X; Gan H; Wang Y; Zhang X; Luo H; Bu G; Xu H; Yao Y; Zhang YW
Exp Mol Med; 2019 Jul; 51(7):1-11. PubMed ID: 31337748
[TBL] [Abstract][Full Text] [Related]
12. mTOR pathway activation in focal cortical dysplasia.
Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
[TBL] [Abstract][Full Text] [Related]
13. Spatial omics reveals molecular changes in focal cortical dysplasia type II.
Vermeulen I; Rodriguez-Alvarez N; François L; Viot D; Poosti F; Aronica E; Dedeurwaerdere S; Barton P; Cillero-Pastor B; Heeren RMA
Neurobiol Dis; 2024 Jun; 195():106491. PubMed ID: 38575092
[TBL] [Abstract][Full Text] [Related]
14. Germline and somatic mutations in the
Møller RS; Weckhuysen S; Chipaux M; Marsan E; Taly V; Bebin EM; Hiatt SM; Prokop JW; Bowling KM; Mei D; Conti V; de la Grange P; Ferrand-Sorbets S; Dorfmüller G; Lambrecq V; Larsen LH; Leguern E; Guerrini R; Rubboli G; Cooper GM; Baulac S
Neurol Genet; 2016 Dec; 2(6):e118. PubMed ID: 27830187
[TBL] [Abstract][Full Text] [Related]
15. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a Dual-Pathway, 2-Hit Genetic Model for Focal Cortical Dysplasia and Epilepsy.
Bennett MF; Hildebrand MS; Kayumi S; Corbett MA; Gupta S; Ye Z; Krivanek M; Burgess R; Henry OJ; Damiano JA; Boys A; Gécz J; Bahlo M; Scheffer IE; Berkovic SF
Neurol Genet; 2022 Feb; 8(1):e652. PubMed ID: 35097204
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
[TBL] [Abstract][Full Text] [Related]
18. mTOR Pathway Somatic Pathogenic Variants in Focal Malformations of Cortical Development: Novel Variants, Topographic Mapping, and Clinical Outcomes.
Krochmalnek E; Accogli A; St-Onge J; Addour-Boudrahem N; Prakash G; Kim SH; Brunette-Clement T; Alhajaj G; Mougharbel L; Bruneau E; Myers KA; Dubeau F; Karamchandani J; Farmer JP; Atkinson J; Hall J; Chantal Poulin C; Rosenblatt B; Lafond-Lapalme J; Weil A; Fallet-Bianco C; Albrecht S; Sonenberg N; Riviere JB; Dudley RW; Srour M
Neurol Genet; 2023 Dec; 9(6):e200103. PubMed ID: 37900581
[TBL] [Abstract][Full Text] [Related]
19. The clinico-pathological characterisation of focal cortical dysplasia type IIb genetically defined by MTOR mosaicism.
Wang Y; Yu T; Blümcke I; Cai Y; Sun K; Gao R; Wang Y; Fu Y; Wang W; Wang Y; Zhang G; Piao Y
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12874. PubMed ID: 36544434
[TBL] [Abstract][Full Text] [Related]
20. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
